Market Place
Sourcing Support
Notable Labs to Present Data on September 4th at SOHO 2024
29 Aug 2024 //
GLOBENEWSWIRE
Notable Labs Announces CEO Transition
26 Aug 2024 //
GLOBENEWSWIRE
Notable Labs Gets FDA Clearance For Volasertib Phase 2 Study
24 Jul 2024 //
GLOBENEWSWIRE
Notable Labs At JMP Securities Life Sciences Conference 2024
09 May 2024 //
GLOBENEWSWIRE
Notable Labs 2023 Results, Business Update
12 Apr 2024 //
GLOBENEWSWIRE
Notable Labs Outlines PPMP-Enabled AML Trial at AACR 2024
09 Apr 2024 //
GLOBENEWSWIRE
Notable Labs Presentation of Data Related to Innovations at AACR 2024
08 Apr 2024 //
GLOBENEWSWIRE
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
05 Mar 2024 //
GLOBENEWSWIRE
Notable Advances Volasertib Phase 2 Program
22 Feb 2024 //
GLOBENEWSWIRE
Notable Reports PPMP Accurately Predicted Fosciclopirox Trial Outcome
18 Dec 2023 //
GLOBENEWSWIRE
Notable Labs to Participate in JMP Securities Hematology and Oncology Summit
04 Dec 2023 //
GLOBENEWSWIRE
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
14 Nov 2023 //
GLOBENEWSWIRE
Notable Labs Announces JCO Precision Oncology Publication
09 Nov 2023 //
GLOBENEWSWIRE
Notable Labs Closes Merger Transaction With VBL Therapeutics
16 Oct 2023 //
GLOBENEWSWIRE
Notable Labs Presents Data Demonstrating PPMP™s Potential
09 Jun 2023 //
GLOBENEWSWIRE
Notable Labs to Present PPMP Data in JMML at EHA Hybrid Congress June 8 – 15
17 May 2023 //
GLOBENEWSWIRE
Notable Labs Presents Clinical Platform Validation Data at the 2023
18 Apr 2023 //
GLOBENEWSWIRE
Notable Labs to Present Results from Clinical Platform Validation Study at AACR
14 Mar 2023 //
GLOBENEWSWIRE
Notable Presents Validation Data from Two Phase 2 Trials in AML at 2021 ASH
16 Dec 2021 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.